Literature DB >> 3530135

Preferential action of rat brain cathepsin B as a peptidyl dipeptidase converting pro-opioid oligopeptides.

N Marks, M J Berg, M Benuck.   

Abstract

Purified rat brain cathepsin B (EC 3.4.22.1) converted prodynorphins or proenkephalins to shorter active forms by the preferential removal of C-terminal dipeptides. The substrate affinities for Met-enkephalin-Arg-Phe or -Arg-Gly-Leu were Km 46 and 117 microM, and kcat/Km ratios were 67 and 115 microM-1, min-1, respectively. Met-Enkephalin was inactivated by the same mechanism (Km-450 microM; kcat/Km = 0.12 microM-1 min-1). The comparison of cathepsin B hydrolysis for pro-opioids, a synthetic hexapeptide and its fragments, C-blocked peptides (pro-opioid amides, Met-enkephalin amide, substance P), and bovine myelin basic protein, provided information on the influence of the C-terminal residues on dipeptide release, the rates as correlated to peptide length, and the optimal arrangement of residues favoring scission at the P1-P'1 sites. The brain enzyme was stereospecific and did not act on peptides with C-terminal D-amino acid substituents. Arg hindered and Pro blocked the release of C-terminal dipeptides when in the P'2 positions. The suppression of dipeptide release by agents inhibiting endopeptidase actions such as E-64 and leupeptin, and the endogenous brain factor (cerebrocystatin) point to similar catalytic mechanisms for the exopeptidase action.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3530135     DOI: 10.1016/0003-9861(86)90026-3

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  8 in total

1.  Decreased metastatic spread in mice homozygous for a null allele of the cystatin C protease inhibitor gene.

Authors:  C G Huh; K Håkansson; C M Nathanson; U P Thorgeirsson; N Jonsson; A Grubb; M Abrahamson; S Karlsson
Journal:  Mol Pathol       Date:  1999-12

2.  Enzyme-substrate interactions in the hydrolysis of peptides by cathepsins B and H from rat liver.

Authors:  D Brömme; K Bescherer; H Kirschke; S Fittkau
Journal:  Biochem J       Date:  1987-07-15       Impact factor: 3.857

3.  Cystatin C, a human proteinase inhibitor, blocks replication of herpes simplex virus.

Authors:  L Björck; A Grubb; L Kjellén
Journal:  J Virol       Date:  1990-02       Impact factor: 5.103

4.  Mononuclear phagocyte hydrolytic enzyme activity associated with cerebral HIV-1 infection.

Authors:  B B Gelman; D A Wolf; M Rodriguez-Wolf; A B West; A K Haque; M Cloyd
Journal:  Am J Pathol       Date:  1997-11       Impact factor: 4.307

5.  The human cystatin C gene (CST3), mutated in hereditary cystatin C amyloid angiopathy, is located on chromosome 20.

Authors:  M Abrahamson; M Q Islam; J Szpirer; C Szpirer; G Levan
Journal:  Hum Genet       Date:  1989-06       Impact factor: 4.132

6.  MNDO study of the mechanism of the inhibition of cysteine proteinases by diazomethyl ketones.

Authors:  M Tarnowska; S Oldziej; A Liwo; P Kania; F Kasprzykowski; Z Grzonka
Journal:  Eur Biophys J       Date:  1992       Impact factor: 1.733

7.  Proteomic analysis of seminal fluid from men exhibiting oxidative stress.

Authors:  Rakesh Sharma; Ashok Agarwal; Gayatri Mohanty; Stefan S Du Plessis; Banu Gopalan; Belinda Willard; Satya P Yadav; Edmund Sabanegh
Journal:  Reprod Biol Endocrinol       Date:  2013-09-03       Impact factor: 5.211

8.  The refined 2.15 A X-ray crystal structure of human liver cathepsin B: the structural basis for its specificity.

Authors:  D Musil; D Zucic; D Turk; R A Engh; I Mayr; R Huber; T Popovic; V Turk; T Towatari; N Katunuma
Journal:  EMBO J       Date:  1991-09       Impact factor: 11.598

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.